Quadrant Capital Group LLC Surmodics Inc Transaction History

Quadrant Capital Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$29.44 - $37.31 $4,945 - $6,268	168 Added 25.11%	837 $28,000
Q3 2022 Nov 10, 2022	BUY	$28.84 - $38.92 $7,844 - $10,586	272 Added 68.51%	669 $20,000
Q2 2022 Aug 09, 2022	BUY	$33.25 - $45.11 $12,468 - $16,916	375 Added 1704.55%	397 $15,000
Q4 2021 Feb 01, 2022	SELL	$43.21 - $57.6 $907 - $1,209	-21 Reduced 48.84%	22 $1,000
Q3 2021 Nov 12, 2021	BUY	$52.8 - $60.32 $897 - $1,025	17 Added 65.38%	43 $2,000
Q2 2021 Aug 09, 2021	BUY	$51.29 - $59.15 $205 - $236	4 Added 18.18%	26 $1,000
Q1 2020 May 15, 2020	BUY	$22.46 - $42.24 $494 - $929	22 New	22 $1,000

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.